0001562180-22-006294.txt : 20220823
0001562180-22-006294.hdr.sgml : 20220823
20220823200258
ACCESSION NUMBER: 0001562180-22-006294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220819
FILED AS OF DATE: 20220823
DATE AS OF CHANGE: 20220823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marks Jason M.
CENTRAL INDEX KEY: 0001878953
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21392
FILM NUMBER: 221188628
MAIL ADDRESS:
STREET 1: C/O AMARIN PHARMA, INC.
STREET 2: 440 US HIGHWAY 22
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMARIN CORP PLC\UK
CENTRAL INDEX KEY: 0000897448
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
BUSINESS PHONE: 353 1 6699 020
MAIL ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
FORMER COMPANY:
FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC
DATE OF NAME CHANGE: 20000201
FORMER COMPANY:
FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC
DATE OF NAME CHANGE: 19930322
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-08-19
false
0000897448
AMARIN CORP PLC\UK
AMRN
0001878953
Marks Jason M.
C/O AMARIN PHARMA, INC.
440 US HIGHWAY 22
BRIDGEWATER
NJ
08807
false
true
false
false
EVP,Chief Global Legal Officer
Ordinary Shares
2022-08-19
4
M
false
33334.00
A
33334.00
D
Ordinary Shares
2022-08-19
4
F
false
11417.00
1.60
D
21917.00
D
Restricted Stock Units
0.00
2022-08-19
4
M
false
33334.00
0.00
D
Ordinary Shares
33334.00
66666.00
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
On September 1, 2021, the Reporting Person was granted 100,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan. These RSUs vest in three equal installments on each of August 19, 2022, August 19, 2023 and August 19, 2024. The first vesting event occurred on August 19, 2022.
Not applicable.
Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
Please see the section titled "Remarks" below for additional information.
Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
In the case of a Change of Control (as defined in the Issuer's stock incentive plan), the grants described in this Form 4 vest in full. As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 746,583 Ordinary Shares of the Issuer in the form of Ordinary Shares, stock options and RSUs outstanding under the Issuer's stock incentive plans, including but not limited to certain performance-based RSUs that are earned only if certain pre-defined operational milestones are achieved and, in certain cases, then vest only if the recipient remains with the company for an extended period of time.
/s/ Jason M. Marks
2022-08-23